The federal government has announced major progress in the fight against Neglected Tropical Diseases (NTDs), with approximately 30 million Nigerians receiving ivermectin treatment for Onchocerciasis (River Blindness) and Lymphatic Filariasis.

The Director of Public Health at the Federal Ministry of Health and Social Welfare (FMoHSW), Godwin Ntadom, disclosed this at the NTD stakeholders’ meeting held on Wednesday in Abuja.

Ntadom said that through collective efforts, Nigeria continues to record steady progress in the fight against Onchocerciasis and Lymphatic Filariasis.

He noted that transmission of Lymphatic Filariasis have been interrupted in 379 LGAs, while the Onchocerciasis Elimination Programme has halted disease transmission in nine states and completely eliminated the disease in two.

Ntadom emphasised that with increased efforts, strategic funding, and strong stakeholder collaboration, Nigeria is on track to eliminate Lymphatic Filariasis as a public health problem.

In his remark, the Director and National Coordinator of the NTD Division at FMoHSW, Fatai Oyediran, acknowledged the support of partners such as the Gates Foundation and Sightsavers.

Oyediran reiterated that Nigeria’s NTD burden is largely driven by Onchocerciasis and Lymphatic Filariasis.

He identified challenges including drug supply chain issues, lack of diagnostics, funding constraints, and insecurity, while stressing the importance of transparency, accountability, and responsible programme implementation.

Oyediran also revealed that the programme, initially set to conclude in February 2025, had been extended to September 2025 to allow for thorough impact assessment.

“By then, around 32 million people are expected to no longer require treatment under the project.”

The Programme Director at Sightsavers Nigeria, Anita Gwom, highlighted the organisation’s more than 20 years of support to endemic communities through medication and preventive care.